There are 2789 resources available
61MO - Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199
Presenter: Julie Graff
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
LBA37 - IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)
Presenter: Arndt Vogel
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
865MO - RMAC study: A randomized study evaluating the efficacy of metronomic adjuvant chemotherapy in patients with recurrent head and neck cancers post salvage surgery, not eligible for re-irradiation
Presenter: Nandini Menon
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
Discussion 963MO, 964MO and 965MO
Presenter: Christian Blank
Session: Mini oral session - Investigational immunotherapy
Resources:
Slides
Webcast
Discussion 860MO, 861MO and 862MO
Presenter: Sara Pai
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Slides
Webcast
Discussion 863MO, 864MO and 865MO
Presenter: Sjoukje Oosting
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Slides
Webcast
Discussion 1670MO and 1443MO
Presenter: Juliane Brandt
Session: Mini oral session - Supportive and palliative care
Resources:
Slides
Discussion 1671MO and LBA62
Presenter: Florian Scotté
Session: Mini oral session - Supportive and palliative care
Resources:
Slides
Webcast
Discussion 1522MO and 1523MO
Presenter: Bernd Kasper
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
Discussion 1526MO and 1527MO
Presenter: Olivier Mir
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast